Total planned funding: $1,057,254,552
Allocations
Countries/Regions
| Nigeria | $202,386,986 |
| Tanzania | $158,622,704 |
| Zambia | $155,383,640 |
| Kenya | $84,718,240 |
| Mozambique | $65,585,852 |
| Uganda | $55,706,806 |
| Ethiopia | $52,369,496 |
| Côte d'Ivoire | $49,720,986 |
| Rwanda | $46,407,155 |
| Zimbabwe | $43,029,022 |
| South Africa | $40,703,583 |
| Haiti | $22,524,484 |
| Namibia | $18,918,851 |
| Democratic Republic of the Congo | $16,224,377 |
| Vietnam | $13,429,876 |
| Eswatini | $9,276,326 |
| Ukraine | $5,044,691 |
| Guyana | $4,315,803 |
| Malawi | $3,548,292 |
| Botswana | $3,308,522 |
| Lesotho | $2,150,000 |
| Cameroon | $888,196 |
| Ghana | $855,016 |
| South Sudan | $659,928 |
| Burundi | $488,020 |
| Indonesia | $369,159 |
| Central America Region | $366,370 |
| China | $116,621 |
| Dominican Republic | $100,000 |
| Central Asia Region | $35,550 |
Organizational Types
| Private Contractor | $1,057,254,552 |
Program Areas
| Treatment | $1,057,254,552 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $772,210,100 |
| HTXS: Treatment: Adult Treatment | $258,421,540 |
| PDTX: Treatment: Pediatric Treatment | $26,622,912 |
Top Partner Programs
Chemonics International:
$510,167,268
View countries
Deloitte Consulting Limited:
$25,996,489
View countries